COVID finger prick, rapid antigen test, or rapid test, is a rapid diagnostic test suitable for point-of-care testing that directly detects the presence or absence of an antigen. It is commonly used for the detection of SARS-CoV-2, the virus that causes COVID-19. Rapid tests are a type of lateral flow tests that detect protein, distinguishing it from other medical tests that detect antibodies or nucleic acid, of either laboratory or point-of-care types. Rapid tests generally give a result in 1 to 15 minutes, require minimal training or infrastructure, and have significant cost advantages. NO Lab Required for results.
For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing.
1.Easy to collect samples simple operation without professional equipment.
2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy.
4.Suitable for large-scale rapid screening.
Shelf life: 24 Months
Test Result time: 10 Mins
Packing: 25 Pieces per Box
Covid-19 Rapid Test Kits Results in 15 Min - MOQ 100,000- $9.15 USD Each Test -FOB-Abbott Antigen BinaxNOW Covid-19 Self Test (Nasal) (No Blood-No Saliva)
RAPID ANTIBODY/Finger Prick 10 to 15 Minute Results
An antibody test is also known as a serology test looks for the presence of antibodies, which are specific proteins made in response to infections. It is effective at detecting the recent past SARS-CoV2 infection. This test can detect the body's IgM Antibody response in as little as 7 days (IgG in 14 days) from infection with CDC validated 100% specificity and 100% sensitivity.
The highest accuracy serological test on the market
FDA EUA Approved
Manufactured by one of the leaders in lateral flow technology
Easy-to-use "All-in-one" test for the detection of anti SARS-CoV-2 antibodies (lgM & lgG)
The Novel Coronavirus 2019-nCoV) lgM/lgG Antibody Combo Test Kit (Colloidal Gold) is intended for the qualitative detection of the antibodies of lgM/lgG against novel coronavirus in serum, plasma, or whole blood from patients with clinical suspicion of 2019-nCoV infection
Rapid SAR-CoV-2 (Covid-19) Test Kits: FDA & CE Approved (Results in 15 min). SAR-CoV-2 IgG/IgM Rapid Test Cassette is a qualitative membrane based immunoassay for the detection of IgG and IgM antibodies to SAR-CoV-2 in human whole blood, serum or plasma specimen. Made in China: FDA and CE Approved, China NMPA approval (export allowed) One of the earliest CE (Feb 2020) and FDA (Mar 2020) approved kit. Clinically studied and reliable. Packaging: 20 sets/box or 40 sets/box. Payment term: MOQ 2000 sets, FOB China $ 9.5/set. < 10000 sets 100% advance payment > 10000 sets L/C ex-work on site
1. Principle
This kit is based on the specific reaction of antibody-antigen and immunochromatography. β-lactam and tetracyclines antibiotics in the sample compete for the antibody with the antigen coated on the membrane of the test strip. Then after a color reaction, the result can be observed.
2. Applications
This kit is used for rapid qualitative analysis of β-lactam and tetracyclines in milk sample.
CE Approved MAU is a rapid visual immune-assay for the qualitative, presumptive detection of albumin in urine for self-testing. The test used as a supplementary method in the diagnosis of diabetic nephropathy and other renal damage. MAU occurs when the kidney leaks small amounts of albumin into the urine.
The first indicator of a renal dysfunction, especially for diabetic patients
Independent risk indicator to evaluate the profession of chronic kidney disease (CKD).
3392 Rapid Test Kits Suppliers
Short on time? Let Rapid Test Kits sellers contact you.
